TINAVI Medical Technologies Co., Ltd. announced a private placement of not more than 62,977,027 shares of class A for gross proceeds not not exceeding CNY 1,340,000,000 on October 25, 2021. The transaction will include participation from no more than 35 investors including securities investment fund management companies, securities companies, trust investment companies, financial companies, asset management companies, insurance institutional investors, and qualified foreign institutional investors, other domestic legal person investors, natural persons or other qualified investors. The company will issue shares at a price of not less than 80% of the average price of the company?s stock trading on the 20 trading days before the pricing base day. The shares to be issued shall have a hold period of six months from the closing of the transaction. The transaction has been approved at the seventh meeting of the fifth board of directors of the company. The transaction still needs to reviewed by The Shanghai Stock Exchange and China Securities Regulatory Commission.